key: cord-1015139-124l6hi0 authors: Balaji, S. M. title: Treatment Algorithm for Orofacial Mucormycosis date: 2021-07-24 journal: Ann Maxillofac Surg DOI: 10.4103/ams.ams_98_21 sha: 3a3ae2d1d69f2f8ecf79a6a5fcb969e6b204fbd5 doc_id: 1015139 cord_uid: 124l6hi0 nan Irrespective of the conditions and forms, mucormycosis of the orofacial region presents as a swelling, painful ulcer or nodule of the jaw bones, sinus and noticeably at the gingiva. If left untreated or under-diagnosed, or late diagnosed, the lesion would undergo a rapid course, destroying all midfacial bone and probably invade the vascular channels to reach the orbit or lungs. When they reach these critical sites, removal of the eye or the affected organs are the only source of treatment. [11] The treatment algorithm for orofacial mucormycosis is very simple. Early diagnosis is the key. [12, 13] Though antifungals such as Amphotericin-B are effective in controlling the spread of the disease, they cannot offer much relief to already infected and necrotized bone. In this situation, the only way to treat is aggressive debridement of the involved areas. Depending on the site -maxilla or mandible, fresh bleeding should be induced. Surgeon should not hesitate to remove dead and necrotic bone. When facing the crucial decision of saving certain parts for future reconstruction, surgeon should not hesitate to remove all offending and affected bone. Leaving back necrotized bone, though under antifungal cover, still predisposes to re-infection. Surgeons must consider the fact that there are plenty of options to recreate a critical sized defect of maxilla and mandible. They could rehabilitate the latter with advanced plates, grafts, and implants and other methodologies can be utilized to recreate lost form and function. [14, 15] With the number of COVID-19 cases plummeting, the effect of the viral infection, known as long-term COVID-19 will soon manifest. Oral Surgeons should be ready to meet the wave of aggressive orofacial fungal infections and possible reconstruction. There might be some hesitancy among surgeons regarding the residual presence of such fungal organisms in the operation theatre. This can be eradicated by following proper operation theatre disinfection protocol. [16, 17] The diagnosis and rehabilitation challenge in severe orofacial mucormycosis would be on the rise due to this second wave of COVID-19 and the oral surgeon community should shoulder the responsibility for early diagnosis, better treatment and later, appropriate reconstruction so that the quality of life would be better. Department of Oral and Maxillofacial Surgery, Balaji Dental and Craniofacial Hospital, Chennai, Tamil Nadu, India. E-mail: smbalaji@gmail.com Why is India having a covid-19 surge? India grapples with second wave of COVID-19. Lancet Microbe Autopsy findings after long-term treatment of COVID-19 patients with microbiological correlation. Virchows Arch Post COVID-19 fungal and microbial infections Maxillofacial Infections in Covid-19 Era-Actuality or the Unforeseen: 2 Case Reports Fungal Infections of Oral Cavity: Diagnosis, Management, and Association with COVID-19 Oral candidiasis of COVID-19 patients: Case report and review of evidence Profile of co-infections and secondary infections in COVID-19 patients at a dedicated COVID-19 facility of a tertiary care Indian hospital: Implication on antimicrobial resistance Mucormycosis in COVID-19: a systematic review of cases reported worldwide and in India Guidelines for the Diagnosis, Staging and Management of Rhino-Orbito-Cerebral Mucormycosis in the Setting of COVID-19 A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India Management of Mucormycosis. Current Fungal Infection Reports Protein-signaled guided total jaw regeneration in infantile total mandibular resection. Ann Maxillofac Surg To distract or not to distract Occurrence of Fungi in the Potable Water of Hospitals: A Public Health Threat Water springing to life the fungal desert